Full Text
The Full Text of this article is available as a PDF (502.5 KB).
Footnotes
HP has received honoraria, educational and travel grants from GlaxoSmithKline, AstraZeneca and Teva.
SH has accepted sponsorship for attending conferences from, has accepted lecture fees from, or has been on advisory boards or provided consultancy for, the following companies; Altana Pharma, AZ, BI, GSK, MEDA Pharmaceuticals, MSD, Chiesi, Novartis and Schering Plough.
MLL has accepted sponsorship from GSK, AstraZeneca (AZ), Chiesi, Merck Sharpe and Dohme (MSD), Merck, Altana Pharma, Novartis, Meda Pharmaceuticals, 3M Pharmaceuticals and Schering Plough for attending conferences. He has accepted lecture fees from Boehringer Ingelheim, GSK, AZ and Alk-Abello. He has been on advisory boards or provided consultancy for Schering Plough, MSD, Cheisi, Altana Pharma, Ranbaxy, AZ, 3M Pharmaceuticals and Novartis. He has received research grants from GSK, AZ and Boehringer Ingelheim. He is a member of ADMIT (The Aerosol Drug Management Improvement Team) which is funded through an unrestricted educational grant by MEDA Pharmaceuticals. MLL is the Editor-in-Chief of the Primary Care Respiratory Journal, but was not involved in the editorial review of, nor the decision to publish, this article.
RMcA has travel grants, sponsorship to attend meetings, honorania for speaker meetings and advisory boards from AZ, GSK, Nycomed, Chiesi and Boeringher in the past year.
IS has received honoraria and travel grants to attend conferences from GSK, AZ, Chiesi, Boehringer Ingelheim, TEVA and Nycomed